Groupe Siparex

Vitacuire is an independent family-owned company specializing in frozen aperitif pastries, with a rich history dating back to its founding in 1952 by Lyon restaurant owners Ginette and Emile Krief. Initially focused on the delivery of frozen puff pastry, the company has evolved under the management of their descendants, including Jean-Yves Krief and his sisters. Vitacuire has established itself as a benchmark player in the market, offering a diverse range of ready-to-cook appetizers such as cocktail bites, individual pastries, and larger shareable options. The company emphasizes innovation and has introduced microwavable cocktail bites and gourmet brioche pastries since the third generation took over in 2010. Vitacuire aims to preserve the nutritional qualities of its products while catering to a wide audience of both young and old customers.

Potager City is a retail company based in Lyon, France, specializing in the delivery of fresh fruit and vegetables. Established in 2007 and now a subsidiary of Carrefour SA, Potager City operates an online platform that connects consumers with local producers. The company focuses on providing seasonal produce through a just-in-time delivery system, ensuring that fruits and vegetables are delivered promptly and directly from farmers to customers' doorsteps. This model emphasizes freshness and supports local agriculture, catering to consumers seeking high-quality, locally sourced food options.

Founded in 1992, CARSO Group specializes in environmental and agrifood analytical services. It offers a wide range of accredited laboratory analyses, including water quality, industrial hygiene, forensic samples, and consumer products, ensuring regulatory compliance and public safety across diverse sectors.

Calixar SAS is a biotechnology company based in Lyon, France, specializing in the deorphanization, identification, and isolation of native and functional integral membrane proteins, which are critical therapeutic targets. Established in 2011, Calixar offers a comprehensive range of services that include the production, extraction, purification, stabilization, and crystallization of membrane proteins, utilizing patented technology to ensure that these proteins maintain their original structure and function. The company focuses on various targets such as GPCRs, ion channels, and transporters, providing essential tools and protocols for drug screening, vaccine development, and structural biology. Its services cater to pharmaceutical companies, biotechnology firms, and academic institutions engaged in antibody development and high-throughput screening assays. By enabling the development of conformational antibodies and new vaccines, Calixar plays a significant role in advancing therapeutic research and drug discovery.